NDC 0409-2300
Ciprofloxacin in Dextrose
Ciprofloxacin
Ciprofloxacin in Dextrose is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc. The primary component is Ciprofloxacin.
| Product ID | 0409-2300_463a68ae-61d4-4fc9-a41f-6ae5d207b5c2 |
| NDC | 0409-2300 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ciprofloxacin in Dextrose |
| Generic Name | Ciprofloxacin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-12-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA078252 |
| Labeler Name | Hospira, Inc |
| Substance Name | CIPROFLOXACIN |
| Active Ingredient Strength | 200 mg/100mL |
| Pharm Classes | Quinolone Antimicrobial [EPC], Quinolones [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |